ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants

Yu, Haisheng; Liu, Banghui; Zhang, Yudi; Gao, Xijie; Wang, Qian; Xiang, Haitao; Peng, Xiaofang; Xie, Caixia; Wang, Yaping; Hu, Peiyu; Shi, Jingrong; Shi, Quan; Zheng, Pingqian; Feng, Chengqian; Tang, Guofang; Liu, Xiaopan; Guo, Liliangzi; Lin, Xiumei; Li, Jiaojiao; Liu, Chuanyu; Huang, Yaling; Yang, Naibo; Chen, Qiuluan; Li, Zimu; Su, Mengzhen; Yan, Qihong; Pei, Rongjuan; Chen, Xinwen; Liu, Longqi; Hu, Fengyu; Liang, Dan; Ke, Bixia; Ke, Changwen; Li, Feng; He, Jun; Wang, Meiniang; Chen, Ling广州医学院; 中国科学院研究生院; 深圳华大基因研究院; 中国科学院; 1
Nature Communications2023-2-24DOI: 10.1038/s41467-023-36761-0
4被引2阅读
引用收藏
分享

摘要

In this study, authors identified neutralizing antibodies by isolating B cells from SARS-CoV-2 Delta infected patients and detect altered structural features, likely introduced by somatic hypermutation, that are involved in epitope binding and increase neutralization breadth against virus variants. @@@ SARS-CoV-2 Omicron variants feature highly mutated spike proteins with extraordinary abilities in evading antibodies isolated earlier in the pandemic. Investigation of memory B cells from patients primarily with breakthrough infections with the Delta variant enables isolation of a number of neutralizing antibodies cross-reactive to heterologous variants of concern (VOCs) including Omicron variants (BA.1-BA.4). Structural studies identify altered complementarity determining region (CDR) amino acids and highly unusual heavy chain CDR2 insertions respectively in two representative cross-neutralizing antibodies-YB9-258 and YB13-292. These features are putatively introduced by somatic hypermutation and they are heavily involved in epitope recognition to broaden neutralization breadth. Previously, insertions/deletions were rarely reported for antiviral antibodies except for those induced by HIV-1 chronic infections. These data provide molecular mechanisms for cross-neutralization of heterologous SARS-CoV-2 variants by antibodies isolated from Delta variant infected patients with implications for future vaccination strategy.

学科与关键词

关键词
CRYO-EMPOTENTMATURATIONINSERTIONSMUTATIONSDELETIONSBROAD
相关
加载中…
  • SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope
    He, Ping; Liu, Banghui; Gao, Xijie; Yan, Qihong; Pei, Rongjuan; Sun, Jing; Chen, Qiuluan; Hou, Ruitian; Li, Zimu; Zhang, Yanjun; Zhao, Jincun; Sun, Hao; Feng, Bo; Wang, Qian; Yi, Haisu; Hu, Peiyu; Li, Pingchao; Zhang, Yudi; Chen, Zhilong; Niu, Xuefeng; Zhong, Xiaolin; Jin, Liang; Liu, Xiaofeng; Qu, Kun; Ciazynska, Katarzyna A.; Carter, Andrew P.; Briggs, John A. G.; Chen, Jizheng; Liu, Jinsong; Chen, Xinwen*; He, Jun*; Chen, Ling; Xiong, XiaoliNature Microbiology, 2022, 7(10): 1635-+.被引 18
  • Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents
    Yan, Qihong; Zhang, Yudi; Hou, Ruitian; Pan, Wenjing; Liang, Huan; Gao, Xijie; Deng, Weiqi; Huang, Xiaohan; Qu, Linbing; Tang, Congli; He, Ping; Liu, Banghui; Wang, Qian; Zhao, Xinwei; Lin, Zihan; Chen, Zhaoming; Li, Pingchao; Han, Jian; Xiong, Xiaoli*; Zhao, Jincun; Li, Song; Niu, Xuefeng; Chen, Ling*Emerging Microbes & Infections, 2024, 13(1): 2290841.
  • Shared IGHV1-69-encoded neutralizing antibodies contribute to the emergence of L452R substitution in SARS-CoV-2 variants
    Yan, Qihong; Hou, Ruitian; Huang, Xiaohan; Zhang, Yanjun; He, Ping; Zhang, Yudi; Liu, Banghui; Wang, Qian; Rao, Haiyue; Chen, Xianying; Zhao, Xinwei; Niu, Xuefeng; Zhao, Jincun*; Xiong, Xiaoli*; Chen, Ling*Emerging Microbes & Infections, 2022, 11(1): 2749-2761.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Nature Communications
发表日期
2023-02-24
卷期
第 14 卷, 第 1 期
页码
1058
DOI
10.1038/s41467-023-36761-0
语言
ENGLISH
成果收录
SCIE
资助标注
Emergency Key Program of Guangzhou Laboratory [EKPG21-06, EKPG21-29, EKPG21-31]; R&D Program of Guangzhou Laboratory [SRPG22-002, SRPG22-003]; Key R&D Program of Guangdong Province [2021A1111110002]; National Key Research and Development Program of China [2021YFC0863300]; Zhongnanshan Medical Foundation of Guangdong Province [ZNSA-2021004]; National Natural Science Foundation of China [82041014, 202100192]; Natural Science Fund of Guangdong Province [2021A1515011289, 2022A1515110495]; Chinese Academy of Sciences; Bioland Laboratory (GRMH-GL)

作者

  • Y

    Yu, Haisheng (第一作者)

    guangzhou med univ

  • L

    Liu, Banghui

    chinese acad sci · guangzhou inst biomed & hlth

查看全部 39 位作者收起作者
  • Z

    Zhang, Yudi

    chinese acad sci · guangzhou inst biomed & hlth · univ chinese acad sci

  • G

    Gao, Xijie

  • W

    Wang, Qian

    1 · guangzhou med univ

  • X

    Xiang, Haitao

    bgi shenzhen

  • P

    Peng, Xiaofang

    guangdong prov ctr dis control & prevent

  • X

    Xie, Caixia

    bgi shenzhen

  • W

    Wang, Yaping

    guangzhou med univ

  • H

    Hu, Peiyu

  • S

    Shi, Jingrong

    guangzhou med univ

  • S

    Shi, Quan

    bgi shenzhen

  • Z

    Zheng, Pingqian

  • F

    Feng, Chengqian

    guangzhou med univ

  • T

    Tang, Guofang

    guangzhou med univ

  • L

    Liu, Xiaopan

    bgi shenzhen

  • G

    Guo, Liliangzi

    guangzhou med univ

  • L

    Lin, Xiumei

    bgi shenzhen

  • L

    Li, Jiaojiao

    guangzhou med univ

  • L

    Liu, Chuanyu

    bgi shenzhen

  • H

    Huang, Yaling

    bgi shenzhen

  • Y

    Yang, Naibo

    bgi shenzhen

  • C

    Chen, Qiuluan

  • L

    Li, Zimu

    chinese acad sci · guangzhou inst biomed & hlth

  • S

    Su, Mengzhen

    chinese acad sci · guangzhou inst biomed & hlth

  • Y

    Yan, Qihong

    1 · guangzhou med univ · chinese acad sci · guangzhou inst biomed & hlth

  • P

    Pei, Rongjuan

  • C

    Chen, Xinwen

  • L

    Liu, Longqi

    bgi shenzhen

  • H

    Hu, Fengyu

    guangzhou med univ

  • L

    Liang, Dan

  • K

    Ke, Bixia

  • K

    Ke, Changwen

  • L

    Li, Feng

    guangzhou med univ

  • H

    He, Jun

    chinese acad sci · guangzhou inst biomed & hlth

  • W

    Wang, Meiniang

    bgi shenzhen

  • C

    Chen, Ling

    chinese acad sci · guangzhou inst biomed & hlth · guangzhou med univ

  • X

    Xiong, Xiaoli

    chinese acad sci · guangzhou inst biomed & hlth

  • T

    Tang, Xiaoping

    guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417